Sensei Biotherapeutics Inc 뉴스 - SNSE | 주식 나스닥 | ADVFN

다우존스 지수

실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Sensei Biotherapeutics Inc (SNSE)
Sensei Biotherapeutics Inc (SNSE) 뉴스

Sensei Biotherapeutics Inc (SNSE)

0.46

0.003

(0.66%)

종가: 21 3월 5:00AM

0.4686

0.0086

( 1.87% )

시간외 거래: 6:06AM

개인 투자자를 위한 전문가급 도구.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 8-K - Current report

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Form 8-K - Current report

Form 8-K - Current report

1
2
다음

tw0122

tw0122 5 월 전

It makes no sense what a pump lol..

Monksdream

Monksdream 10 월 전

Either that or a lousy result from a clinical trial

The Night Stalker

The Night Stalker 10 월 전

was there offering

Monksdream

Monksdream 10 월 전

Monksdream

Monksdream 1 년 전

Invest-in-America

Invest-in-America 1 년 전

SNSE: Not the easiest 'NEWS' to interpret, but nevertheless anything reasonably-POSITIVE about killing CANCER may send it flying-UP in price.
https://finance.yahoo.com/news/sensei-biotherapeutics-reports-favorable-clinical-200500820.html

Monksdream

Monksdream 1 년 전

SNSE new 52 week low

Monksdream

Monksdream 1 년 전

SNSE new 52 week low

Monksdream

Monksdream 2 년 전

SNSE new 52 week low

Monksdream

Monksdream 2 년 전

SNSE new 52 week low

Monksdream

Monksdream 2 년 전

SNSE new 52 week low

Monksdream

Monksdream 2 년 전

SNSE new 52 week low

Monksdream

Monksdream 2 년 전

SNSE new 52 week low

Clemdane

Clemdane 2 년 전

Anyone else looking at this company? Small anti-aging biotech (senolytics). Affiliated with private Cambrian Biopharma, a large shareholder in SNSE and Tornado Therapeutics which is testing mTOR inhibitors as potential longevity drugs. Will post more DD here. Read about them in Fortune: https://fortune.com/well/2023/02/23/reverse-aging-breakthroughs-in-science/:

Sensei Biotherapeutics

Pasithea Therapeutics

Acadian Ventures Fund Ii

Barinthus Biotherapeutics

OMX Stockholm Industrial...

Ocular Therapeutix

Fidelity Europe Qlty Inc...

United Internet

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관